A veteran filling a 30-day prescription at a VA pharmacy pays a flat copay — as little as $5, capped at $700 total for the year no matter how many medications they need. That predictable bill is possible partly because the VA just posted its biggest pharmaceutical price win on record: $10.44 billion in negotiated drug-price cuts so far in fiscal year 2026, up from $7.99 billion the year before. The savings do not directly lower what an individual veteran owes at the counter, but the VA says they are why it can keep treating more veterans without raising that bill.
What the VA Actually Negotiated
The VA announced on August 13 that it has secured $10.44 billion in pharmaceutical price reductions during fiscal year 2026, which was not yet finished when the figure was released. That total is up from $7.99 billion in price cuts in fiscal 2025 and $5.23 billion in fiscal 2024 — a trajectory the department says reflects an intensified effort to negotiate lower prices on the medications it buys most often for veterans.
VA Secretary Doug Collins credited the increase to “smart, tough negotiations with drugmakers,” and the department said the savings let it stretch pharmaceutical spending across more patients while preserving room in the budget for newer, more expensive therapies as they reach the market. The VA did not break out which specific drugs or drug classes drove the largest share of the fiscal 2026 total in its announcement.
The VA has long negotiated drug prices differently than Medicare has historically been allowed to. As a single national health system with a unified drug list, the VA can negotiate directly with manufacturers and access statutory discounts unavailable to Medicare Part D plans — a structural advantage a 2020 federal watchdog report found let the VA pay, on average, 54% less per unit than Medicare Part D for a sample of 399 brand-name and generic drugs in 2017. Medicare has since gained its own negotiating power for a limited set of drugs under 2022 legislation, narrowing but not eliminating that historical gap.
Free retirement updates: Want plain-English help keeping more of your money in retirement? The free Retirement Shield newsletter covers the benefits, deadlines, and money mistakes that cost retirees, a couple times a week. Subscribe free.
What a Veteran Actually Pays at the Pharmacy
None of the $10.44 billion figure describes what an individual veteran pays out of pocket — that is governed separately by the VA’s medication copay rates. Veterans with a service-connected disability rating of 50% or higher, those the VA has determined cannot work because of a service-connected disability, and Medal of Honor recipients pay no medication copay at all. For most other enrolled veterans, medications for conditions unrelated to military service fall into a tiered copay system.
For a 30-day supply, a preferred generic runs $5, a non-preferred generic or certain over-the-counter drug runs $8, and a brand-name prescription runs $11 — figures that roughly double for a 60-day supply and roughly triple for 90 days. Once a veteran’s medication copays reach $700 in a calendar year, the VA stops charging for any further prescriptions for the rest of that year, regardless of how many refills or new medications follow.
Who Is Exempt, and Why the Cap Matters
Veterans in priority group 1 — those with a service-connected disability rated 50% or higher, those the VA has determined unemployable because of a service-connected disability, or Medal of Honor recipients — pay no medication copay under any circumstance. Veterans in priority groups 2 through 8 face the tiered copay schedule only for medications treating conditions unrelated to their military service; medications tied to a rated service-connected disability generally carry no copay at all.
A veteran with a service-connected disability rating of 40% or less whose household income falls at or below the VA’s published income limits can also ask the department to determine eligibility for free medications, regardless of which tier a prescription falls into. And no matter which tier or income bracket applies, the $700 annual medication copay cap resets every January 1, meaning a veteran managing several chronic prescriptions could plausibly stop paying entirely partway through the year.
Many veterans also qualify for Medicare, and some fill certain prescriptions through a Part D plan instead of VA pharmacy when a drug isn’t on the VA’s formulary or a private pharmacy is simply more convenient. Because VA copays are generally lower than commercial Part D copays for a comparable drug tier, filling a covered prescription through VA pharmacy benefits typically costs less out of pocket than routing the same drug through Medicare — part of why the department frames its formulary negotiating leverage as a veteran-facing benefit, not only a federal budget line.
What remains unclear is how the pace of savings holds up once fiscal 2026 closes at the end of September and VA negotiators face a pipeline increasingly dominated by expensive specialty and biologic drugs, the category driving most of the growth in national drug spending. For now, the department is describing the $10.44 billion as a budget cushion rather than a rebate — the benefit shows up in the VA’s ability to keep its copay schedule where it is and treat more veterans, not as a check mailed to any individual patient.
This article was researched and drafted with the assistance of artificial intelligence.
More Financial Reading
